Accera to Present at Upcoming Healthcare and Investor Conferences

Accera, Inc., a clinical-stage biotechnology company focused on product development for Alzheimer's disease, today announced that the company will present at the following upcoming investor conferences: 16th Annual Biotech in Europe Forum: Dr. Charles Stacey, president and CEO, will present an overview of the company on Tuesday, September 27, at 4 p.m. CEST at the Congress Center in Basel, Switzerland. Dr. Stacey will also participate in an Alzheimer's disease panel at 2 p.m. CEST on the same day. The panel includes representatives from Novartis Institutes for BioMedical Research, Eli Lilly and Company, SV Life Sciences, Alzheimer's Research UK and Heptares Therapeutics.